Seasoned private equity and corporate finance professional focused on growth-stage technology and healthcare investments. Jeffrey D Matchett-Robles brings experience in deal sourcing, due diligence, portfolio operations and capital markets strategy across cross-border transactions. Often works with founder-led teams to scale go-to-market, optimize financial operations and prepare companies for liquidity events. Active in board advisory roles and fundraising for mid-market buyouts and growth equity strategies.
Seasoned private equity and corporate finance professional focused on growth-stage technology and healthcare investments. Jeffrey D Matchett-Robles brings experience in deal sourcing, due diligence, portfolio operations and capital markets strategy across cross-border transactions. Often works with founder-led teams to scale go-to-market, optimize financial operations and prepare companies for liquidity events. Active in board advisory roles and fundraising for mid-market buyouts and growth equity strategies.
Focuses on growth-stage technology and healthcare companies where operational improvement and capital structure optimization unlock scale. Prefers founder-led opportunities with clear go‑to‑market expansion plans, applying rigorous due diligence, hands‑on portfolio operations and board-level governance to accelerate revenue and margin expansion. Capital allocation emphasizes growth equity and mid‑market buyouts with staged financing, milestone‑linked capital and exit planning toward strategic sales or IPOs. Risk discipline blends deep sector expertise, cross‑border deal execution and capital markets timing to balance upside from operational value creation with downside protection via covenants and active oversight.
Focuses on growth-stage technology and healthcare companies where operational improvement and capital structure optimization unlock scale. Prefers founder-led opportunities with clear go‑to‑market expansion plans, applying rigorous due diligence, hands‑on portfolio operations and board-level governance to accelerate revenue and margin expansion. Capital allocation emphasizes growth equity and mid‑market buyouts with staged financing, milestone‑linked capital and exit planning toward strategic sales or IPOs. Risk discipline blends deep sector expertise, cross‑border deal execution and capital markets timing to balance upside from operational value creation with downside protection via covenants and active oversight.
| Trades 284 | Longs Won 230/284 80% | Profit Factor 50.62 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $979,793.76 |
| Average Win $200,620.65 | Best Trade (Aug 14) $13.14M | Sharpe Ratio -10.58 |
| Average Loss -$16,880.49 | Worst Trade (Aug 19) -$265,765.82 | Z-Score 17.22 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 1w 6d | Expectancy $159,264.8 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.28% |
| Consecutive Losing Trades | 10,000 | 9,000 | 8,000 | 7,000 | 6,000 | 5,000 | 4,000 | 3,000 | 2,000 | 1,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 10,821 | $2.38M | $3.34M | - | $960,635.77 | 40.33% | -7.354% |
AMGN Amgen Inc. | 856 | $275,377.45 | $329,696.96 | - | $54,319.51 | 19.73% | -0.64% |
AMZN Amazon.com Inc | 4,336 | $844,645.17 | $1.18M | - | $332,925.67 | 39.42% | +15.321% |
AVGO Broadcom Inc. | 898 | $254,798.01 | $349,573.44 | - | $94,775.43 | 37.2% | +0.371% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 427,134 | $32.69M | $32.27M | - | -$429,115.87 | -1.31% | -0.198% |
BND Vanguard Total Bond Market Index Fund | 30,520 | $2.23M | $2.2M | - | -$25,426.17 | -1.14% | -0.262% |
BNDX Vanguard Total International Bond ETF | 5,773 | $277,398 | $275,776.21 | - | -$1,621.79 | -0.58% | -0.23% |
BRK-B Berkshire Hathaway Inc. | 1,852 | $664,828.52 | $947,372.08 | - | $282,543.56 | 42.5% | +0.365% |
CAT Caterpillar Inc. | 420 | $240,872.58 | $342,220.2 | - | $101,347.62 | 42.08% | +0.701% |
CL Colgate-Palmolive Company | 5,600 | $581,336 | $511,280 | - | -$70,056 | -12.05% | -0.328% |
COST Costco Wholesale Corporation | 362 | $322,921.92 | $344,584.18 | - | $21,662.26 | 6.71% | -0.239% |
CVX Chevron Corporation | 1,600 | $235,632 | $314,928 | - | $79,296 | 33.65% | +2.35% |
DFAU Dimensional US Core Equity Market ETF | 6,532 | $276,732.25 | $338,226.96 | - | $61,494.71 | 22.22% | +0.544% |
DFEM Dimensional Emerging Markets Core Equity 2 ETF | 17,294 | $474,246.51 | $651,983.8 | - | $177,737.29 | 37.48% | +0.426% |
DFIC Dimensional International Core Equity Market ETF | 69,012 | $1.85M | $2.63M | - | $775,108.32 | 41.82% | -0.574% |
DFUV Dimensional US Marketwide Value ETF | 5,189 | $251,475 | $288,456.51 | - | $36,981.51 | 14.71% | +0.216% |
EAGG iShares ESG Aware U.S. Aggregate Bond ETF | 7,125 | $339,227.52 | $332,381.25 | - | -$6,846.27 | -2.02% | -0.214% |
ESGV Vanguard ESG U.S. Stock ETF | 5,501 | $510,118.06 | $726,242.04 | - | $216,123.98 | 42.37% | +0.679% |
EXPD Expeditors International of Washington, Inc. | 1,790 | $235,206 | $300,523.1 | - | $65,317.1 | 27.77% | +0.527% |
FITB Fifth Third Bancorp | 5,310 | $227,480 | $300,015 | - | $72,535 | 31.89% | -0.159% |